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Introduction: The increasing use of computed tomography (CT) has led 
to frequent identification of asymptomatic lesions in the anterior medias-
tinum. The purpose of this study is to identify CT features that distinguish 
benign thymic lesions from early-stage malignant thymic neoplasms.
Methods: We retrospectively reviewed preoperative CT imaging for 
66 patients, who had undergone thymectomy for benign thymic lesions 
or early-stage malignant thymic neoplasms. All variables with a p value 
of less than 0.2 on univariate logistic regression analysis were evalu-
ated by multivariate analysis. Stepwise selection was performed, and 
variables with a p value less than 0.05 were retained in the final model.
Results: Thirty-eight malignant (58%) and 28 benign thymic lesions 
(42%) were included. Patients with benign thymic tumors were sig-
nificantly younger (median age, 49.5 years) than patients with malig-
nant tumors (60.0 years; p = 0.007). Malignant tumors were larger in 
short-axis dimension (p = 0.028) and more frequently in a nonmid-
line location in the anterior mediastinum (p = 0.029). Intralesional 
fat was seen exclusively in benign masses (p = 0.002). Seven benign 
tumors (25%) and one malignant tumor (2.6%) had a triangular thy-
mic shape (p = 0.023). In multivariate analysis, lower age, smaller 
short-axis dimension, and lack of infiltration of the mediastinal fat 
were significant independent predictors of benign pathologic results.
Conclusion: Intralesional fat, midline location, and triangular thy-
mic shape are more frequently found in benign thymic lesions. Lack 
of infiltration of the mediastinal fat, younger patient age, and smaller 
size are independent predictors of benign thymic lesions. These fea-
tures may help characterize thymic masses as benign and avert poten-
tially unnecessary invasive diagnostic procedures.
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The normal thymus evolves over the course of a lifetime, with involution and gradual fatty replacement beginning 
around puberty. The thymus originates from three embryonic 
germ-cell layers and thus, has the potential to transform along 
a number of neoplastic cell lines.1–3 On computed tomography 
(CT), the normal thymus appears as a triangular-shaped struc-
ture in the anterior mediastinum. Variations in the morphology 
of the normal thymus gland, along with its association with a 
diverse range of pathologic processes, can make the thymus 
an imaging enigma and diagnostic challenge for clinicians.4,5
An abnormal appearance of the thymus can be attribut-
able to either diffuse enlargement of the gland or a discrete 
mass. Benign thymic hyperplasia and lymphoma can both 
cause diffuse enlargement of the thymus. Many lesions—
including thymoma, thymic carcinoma, and thymic carci-
noids—as well as benign lesions—such as thymolipomas and 
cysts—can present with a focal thymic mass. This is often 
an incidental finding in an asymptomatic patient undergoing 
imaging for unrelated reasons. Clinical presentation can play 
a role in the evaluation of patients with thymic masses. One 
study found that more than 75% of asymptomatic patients 
with mediastinal masses had benign lesions, whereas, almost 
two thirds of symptomatic patients with mediastinal masses 
had malignant lesions.6 It has been suggested that expectant 
management can be considered for observation of asymptom-
atic patients with diffuse thymic enlargement. For symptom-
atic patients, biopsy or at times, resection may be appropriate.7
At present, CT remains the imaging modality of choice 
for the evaluation of mediastinal masses. Magnetic resonance 
imaging and positron emission tomography are useful 
adjuncts.8 Although there is overlap in the features of many 
thymic lesions on imaging, some lesions have a characteristic 
appearance on CT. Thymolipoma, an uncommon benign 
thymic neoplasm, typically manifests on CT as a large anterior 
mediastinal mass containing fat intermingled with areas of 
soft-tissue attenuation, which may conform to the shape of 
other mediastinal structures.9,10 On CT, idiopathic multilocular 
thymic cyst, an acquired benign thymic lesion, cannot be 
reliably distinguished from the cystic components of malignant 
thymic lesions, including thymomas, Hodgkin’s lymphoma, 
and mediastinal germ-cell tumors.11 The appearances of 
thymomas on imaging can vary according to their staging 
and histologic subtype; lobulated contours, calcifications, and 
heterogeneous attenuation are associated with more advanced, 
rather than early-stage, thymoma.12
The increasing use of CT has led to frequent identification 
of incidental lesions in the anterior mediastinum, and with recent 
advances in minimally invasive surgical techniques, an increasing 
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number of thymic lesions are referred for surgical evaluation. 
Consequently, some patients may undergo invasive procedures 
for ultimately benign disease. If the benignity of a thymic lesion 
could be determined on imaging with a reasonable level of con-
fidence, then the need for invasive procedures may potentially 
be obviated for a number of cases.7 The purpose of this study is 
to identify imaging features that help distinguish benign thymic 
lesions from early-stage malignant thymic neoplasms.
PATIENTS AND METHODS
Patient Selection
Our institutional review board granted approval and 
waived the informed consent requirement for this retrospective 
study. Patients were identified from a prospectively maintained 
database of surgical procedures. Patients who underwent com-
plete thymic resections for benign lesions or early-stage thy-
mic malignant neoplasms at our institution between January 
2007 and September 2010 were included. Early-stage thymic 
malignancy was defined as stage I or II by the Masaoka-Koga 
classification system,13 and patients who received neoadjuvant 
therapy were excluded. We excluded advanced-stage thymic 
malignancies, as these often demonstrate more aggressive fea-
tures on CT, such as vascular invasion, making them easier to 
distinguish from benign processes. Clinical information was 
abstracted retrospectively from medical records.
Imaging Analysis
All preoperative CT scans were retrospectively reviewed 
in a consensual manner by two radiologists (MSG and AM) 
with a combined 16-year experience postradiology fellowship 
training. Radiologists were blinded to the pathologic diagnoses 
and clinical details of the patients at the time of interpretation 
of the scans. All images were reviewed on a picture-archiving 
and communication system (GE PACS; Waukesha, WI). 
CT-imaging protocols varied, as many patients were referred 
from a range of institutions to our tertiary referral center after 
their initial imaging. Imaging was performed on a variety of 
multidetector CT scanners, with slice thicknesses ranging 
from 1.25 to 5 mm. Forty-two patients (64%) received intra-
venous contrast.
Imaging findings were assessed in accordance with the 
standard CT reporting terms for mediastinal masses suspi-
cious for thymic malignancy, as defined by the International 
Thymic Malignancy Interest Group.14 The features on CT 
included size, location, contour, shape, and attenuation. We 
defined lesion location within the mediastinum as anterior 
mediastinal if the lesion was located posterior to the sternum 
and anterior to the heart, from the left brachiocephalic vein 
to the diaphragm, between the right and left parietal pleura. 
The location was further subdivided into right, left, or midline, 
according to its position relative to a line drawn between the 
midsternum and the trachea.
The longest lesion dimension on axial imaging and its 
perpendicular short-axis measurement on the same slice were 
FIGURE 1.  Triangular thymic-shaped anterior mediastinal 
mass on computed tomography in a 31-year-old woman. 
The mass was histologically confirmed to be benign thymic 
tissue after resection.
FIGURE 2.  Lymphangioma in a 35-year-old woman. Cystic 
well-defined, left-sided thymic mass on contrast-enhanced 
computed tomography (13 HU).
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obtained. The lesion contour was defined as smooth in the 
absence of spiculation, ill-defined border, or lobulation, and 
as lobulated in the presence of one or more lobulations, which 
are characterized as convex tumor contours with adjacent 
notches between tumor lobules. The shape was classified as 
round if the ratio between long-axis and short-axis was less 
than 1.5, as oval if the ratio was greater than or equal to 1.5, 
and as thymic shape if the lesion had a triangular configuration 
(Fig. 1). Attenuation was assessed by visual inspection and 
categorized as homogeneous, if the lesion was of uniform 
attenuation, and as heterogeneous, if there were areas of low 
attenuation within the lesion. The presence of macroscopic 
intralesional fat, calcifications, and cystic components was 
assessed (Figs. 2–5). Lesions demonstrating homogeneous 
water attenuation were considered cystic. Calcifications were 
described as curvilinear, punctate or coarse. Clear infiltration 
of the mediastinal fat by the lesion was noted (Fig. 6); however, 
the absence of a visible fat plant between abutting surfaces 
was not considered to indicate infiltration.
Statistical Analysis
Logistic regression and Fisher’s exact test were used 
for univariate analysis. Variables with a p value less than 0.2 
on univariate analysis were evaluated by multivariate analy-
sis. A multivariate logistic regression model was constructed, 
using stepwise selection, in which only variables with an over-
all p value less than 0.05 were retained in the final model. 
p Value less than 0.05 was considered to indicate statistical 
significance. All analyses were conducted using SAS version 
9.2 (SAS Institute, Cary, NC).
RESULTS
The study group consisted of 66 patients (32 men and 34 
women; age range, 22–88 years; median age, 57 years). Twenty-
one patients (32%) had a history of nonthymic malignancy. 
Thirty-one patients (47%) reported chest-related symptoms 
(pain, shortness of breath, cough, and symptoms warrant-
ing cardiac evaluation), which prompted their initial imaging 
assessment. Two patients underwent CT imaging for evalua-
tion of symptomatic myasthenia gravis; both had thymomas on 
pathologic analysis. For the remaining 33 patients (50%), ante-
rior mediastinal masses were incidentally detected on imaging 
performed for a variety of clinical indications (Table 1).
Of the 66 patients in the study group, 38 (58%) had 
malignant thymic lesions, and 28 (42%) had benign lesions. 
The malignant lesions included thymoma, thymic carcinoma, 
thymic carcinoid, and thymic lymphoma, whereas, the 
benign group was more heterogeneous and included a wide 
spectrum of pathologies (Table 2). Patients with malignant 
thymic tumors were significantly older (p = 0.007), with a 
median age of 60 years (range, 34–88 years), compared with 
49.5 years (range, 22–77 years) in the benign group. All 
lesions were completely resected (Table 3). An open surgical 
approach was used in 40 patients (61%), which included 
13 patients with benign lesions (46% of the benign study 
group) and 27 patients with malignant lesions (71% of the 
malignant study group). Of the remaining 26 patients (39%), 
12 (43%) of those with benign lesions and eight (21%) of 
FIGURE 3.  Simple thymic cyst in a 62-year-old woman. 
Noncontrast computed tomography image shows a low-atten-
uation (10 HU) cystic left-sided anterior mediastinal mass.
FIGURE 4.  Example of macroscopic intralesional fat (arrow-
heads) in pathologically confirmed true thymic hyperplasia in 
a 48-year-old man.
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those with malignant lesions underwent robotically assisted 
minimally invasive resection. The remaining six patients 
(9%) underwent standard thoracoscopic resection. The most 
common reason for surgery was to rule out malignancy 
(97%); the remaining two patients (3%) underwent surgery 
for symptomatic myasthenia gravis.
The results of the univariate analysis of CT findings, 
for all thymic lesions, are summarized in Table 4. Malignant 
tumors were larger, with a statistically significant difference 
in short-axis dimension (p = 0.028): for malignant and benign 
thymic tumors, median short-axis dimensions were 31 mm 
(range, 12–89 mm) and 19.5 mm (range, 10–56 mm), respec-
tively. Anterior mediastinal location differed significantly (p = 
0.029): benign lesions were more frequently located in the 
midline and less frequently located to the left or the right of 
the midline, compared with malignant lesions (Figs. 7 and 8).
There were significant differences in tumor shape 
(p = 0.023): seven benign thymic tumors (25%) had a thy-
mic shape, compared with one malignant tumor (3%), which 
was shown to be a thymoma on final histologic analysis. 
Macroscopic intralesional fat was seen in seven benign tumors 
(25%) and in zero malignant tumors (p = 0.002). The major-
ity of tumors did not have calcifications (p = 0.417) and more 
often had a smooth (n = 44; 67%) rather than a lobulated (n = 
22; 33%) contour (p = 0.083). Lesion attenuation (p = 0.892) 
was not significantly different between benign and malignant 
lesions. Four benign lesions (14%) and one malignant lesion 
(3%) were cystic. Infiltration of the mediastinal fat was visual-
ized on CT in 10 patients: One (4%) had a benign tumor with 
pathologic results demonstrating thymic hyperplasia, and nine 
(24%) had malignant tumors, four of which had mediastinal 
fat invasion on histologic analysis (p = 0.051).
In multivariate analysis, patient age, short-axis dimen-
sion, and lack of infiltration of the mediastinal fat remained 
significantly associated with benign pathologic results (Table 
5). As none of the malignant tumors had macroscopic intra-
lesional fat on CT, this feature could not be analyzed in the 
multivariate model. For each year of increase in age, the odds 
of having a benign lesion decreased by 7% (odds ratio [OR], 
0.93; 95% confidence interval [CI], 0.89–0.98; p = 0.003). 
With regard to size, for each millimeter increase in short-axis 
dimension, the odds of the lesion being benign decreased by 
5% (OR, 0.95; 95% CI, 0.91–1.00; p = 0.040). With medias-
tinal fat infiltration present, lesions were 92% less likely to be 
benign, than when mediastinal fat infiltration was absent (OR, 
0.08; 95% CI, 0.001–0.85; p = 0.036).
DISCUSSION
Thymic tumors are relatively uncommon, and a diverse 
spectrum of pathologic processes can affect the thymus, as 
reflected in our study. Because of its location, lesions in the 
thymus are not always readily accessible by percutaneous 
biopsy. Many patients may undergo invasive procedures for 
ultimately benign disease. Twenty-eight patients in our study 
underwent resection, and 13 patients underwent sternotomy, 
for ultimately benign disease. Our aim was to identify features 
on CT imaging, which would assist in distinguishing benign 
thymic masses from early-stage thymic malignances.
FIGURE 5.  Heterogeneous anterior mediastinal mass con-
taining fat (arrowheads) intermingled with areas of soft-tissue 
attenuation in a 37-year-old man; the mass was confirmed as 
a thymolipoma on histological analysis after resection.
FIGURE 6.  Mediastinal fat invasion (arrowheads), confirmed 
by pathologic analysis, in an 87-year-old man with thymoma.
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Our findings concur with those of previous studies, 
which found that malignant thymic tumors occur in an older 
patient population. In a European study, the median age at 
diagnosis was 59 years; in the United States, the mean age was 
56 years.1,15,16 From a demographic standpoint, we found that 
indeterminate thymic lesions in younger patients (<43 years) 
tended more often to be benign.
Symptomatology has been described as a useful pre-
dictor of malignancy in patients with mediastinal masses. 
In one study, up to two thirds of symptomatic patients had a 
malignancy.6 Singla et al.7 found that the presence of thoracic 
symptoms, such as chest discomfort or shortness of breath, 
was a useful discriminator in patients with a diffusely enlarged 
thymus gland on CT. Of 36 patients with thymic hyperplasia, 
no asymptomatic patient had malignant findings on resection, 
leading the authors to conclude that follow-up with serial 
imaging, rather than biopsy, may be appropriate. With the 
exception of myasthenia, there are no specific symptoms that 
can be definitively attributed to the thymus gland. In our study, 
50% of patients had either symptoms anatomically attribut-
able to the chest or myasthenia; of these, 58% (19 patients) 
had malignant lesions compared with 42% (14 patients) who 
had benign lesions. Therefore, in our experience, clinical pre-
sentation would not help in the diagnostic algorithm.
Although most of the thymic lesions in our study were 
located to the right or left of the midline, 39% of benign 
masses, compared with only 10% of malignant tumors, were 
midline, although this association did not retain statistical sig-
nificance in multivariate analysis. This finding is somewhat 
comparable with those of studies of thymic epithelial tumors, 
which found that less than 25% of lesions were in the mid-
line.17,18 We found that malignant tumors were significantly 
larger in short-axis dimension than benign tumors. In a small 
study by Travaini et al.,19 all benign lesions (8 out of 8 masses) 
were less than 5 cm in long-axis dimension, compared with 
only three of 12 malignant lesions. This pattern is also seen 
in the spectrum of thymic epithelial tumors. Thymic carci-
nomas, which exhibit more aggressive behavior and a poorer 
outcome, compared with thymomas, have been shown to be 
significantly larger.17
Identification of thymic mass morphology may be help-
ful. In our study group, in univariate analysis, lesions that 
retained a triangular thymic shape were significantly more 
likely to be benign, compared with those with a round or oval 
shape. Jeong et al.18 found that thymic epithelial tumors with 
an oval shape had a worse prognosis. In our series, the pres-
ence of macroscopic intralesional fat was seen exclusively 
in benign tumors; however, we had no cases of teratoma or 
malignant germ-cell tumor, which can have macroscopic fat 
visible on CT,20 and we were not able to examine this feature 
in multivariate analysis. In 97% of our patients, malignancy 
could not be ruled out by CT alone, prompting additional 
TABLE 1.  Indication or Symptoms Precipitating Initial Imaging
Indication/symptom(s) Overall (n = 66) Benign (n = 28) Malignant (n = 38)
Respiratory symptoms 15 (22.7%) 5 10
Chest pain 13 (19.7%) 8 5
Staging of nonthymic cancer 9 (13.6%) 5 4
Nonrespiratory indicationsa 9 (13.6%) 3 6
Routine imagingb 9 (13.6%) 2 7
Cardiovascular imaging 4 (6.1%) 1 3
Unknown reason 3 (4.5%) 2 1
Evaluation of pleural effusions/retrosternal goiter 2 (3.0%) 2 0
Myasthenia gravis 2 (3.0%) 0 2
aIncluding trauma, positive tuberculin skin test, anemia, renal colic, hematuria, back pain, and high white cell count.
bFor example, preoperative chest radiograph.
TABLE 2.  Pathologic Diagnosis
Pathologic Diagnosis No. (%)
Benign
 Thymic cyst 10 (15.2)
 Thymic hyperplasia 6 (9.1)
 Benign thymus 3 (4.5)
 Thymolipoma 3 (4.5)
 Benign nodular thyroid hyperplasia 1 (1.5)
 Bronchogenic cyst 1 (1.5)
 Cystic lymphoid thymic hyperplasia 1 (1.5)
 Fibrous tumor 1 (1.5)
 Lymphangioma 1 (1.5)
 Thymic fibrosis 1 (1.5)
Malignant
 Thymoma 32 (48.5)
 Thymic carcinoma 3 (4.5)
 Thymic carcinoid 2 (3)
 Thymic lymphoma 1 (1.5)
TABLE 3.  Surgical Approach
Surgical Approach
Overall  
(n = 66)
Benign  
(n = 28)
Malignant 
(n = 38)
VATS 26 (39.4) 15 (53.6) 11 (28.9)
 Standard 6 (9.1) 3 (10.7) 3 (7.9)
 Robotically assisted 20 (30.3) 12 (42.8) 8 (21.0)
Open 40 (60.6) 13 (46.4) 27 (71.1)
Data are no. (%).
VATS, video-assisted thoracoscopic surgery.
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diagnostic procedures. This finding indicates that our ability 
to discern a benign lesion from a malignant one leaves room 
for improvement.
Evidence of infiltration of the mediastinal fat on CT 
is associated with more aggressive malignant tumors of the 
thymus. Jeong et al.18 observed mediastinal fat invasion more 
often in thymic carcinomas (5 of 15) than in low-grade thy-
momas (1 of 31) (p = 0.033). Jung et al.17 had similar findings. 
In our study, we identified infiltration of the mediastinal fat 
on CT in one benign lesion (which was determined to be thy-
mic hyperplasia on histologic analysis) and in nine malignant 
lesions, four of which had confirmed mediastinal fat invasion 
on histologic analysis, which concurs with published results. 
Infiltration of the mediastinal fat remained a strong indepen-
dent predictor in multivariate analysis.
The small number of patients in our cohort is a limita-
tion of our study, and additional confirmation of our findings 
by use of a larger study group would certainly be valuable. 
However, thymic tumors are uncommon. In one population 
study, the incidence of thymomas was reported as 3.2 per 1 
million people.15 In addition, CT imaging did not follow a 
standardized protocol, which was inevitable, because many 
patients were referred to our tertiary referral oncology center 
after initial evaluation at other institutions. However, to our 
knowledge, our study is the largest to compare the imaging 
features of benign and malignant thymic lesions. Travaini et 
al.19 evaluated the role of F-18-fluorodeoxyglucose positron 
emission tomography CT to differentiate benign and malig-
nant thymic masses but were limited by a small sample size 
of 20 patients. In a study of 109 thymic masses, Singla et al.7 
recommend that it is reasonable to observe asymptomatic 
patients with diffusely enlarged thymic glands by use of serial 
CT imaging; however, they did not address the imaging char-
acterization of discrete thymic masses seen on CT.
TABLE 4.  Univariate Analysis
Variable Overall (n = 66) Benign (n = 28) Malignant (n = 38) pa
Age (yr)b 57 (22–88) 49.5 (22–77) 60 (34–88) 0.007
Sex 0.433
 Male 32 (48.5) 12 (42.9) 20 (52.6)
 Female 34 (51.5) 16 (57.1) 18 (47.4)
Cancer history 0.961
 Yes 21 (31.8) 9 (32.1) 12 (31.6)
 No 45 (68.2) 19 (67.9) 26 (68.4)
Size (mm)b
 Long-axis 38 (12–144) 33.5 (12–74) 40.5 (15–144) 0.226
 Short-axis 25 (10–89) 19.5 (10–56) 31.0 (12–89) 0.028
Location 0.029
 Left 33 (50.0) 12 (42.9) 21 (55.3)
 Right 18 (27.3) 5 (17.9) 13 (34.2)
 Midline 15 (22.7) 11 (39.3) 4 (10.5)
Contour 0.083
 Smooth 44 (66.7) 22 (78.6) 22 (57.9)
 Lobulated 22 (33.3) 6 (21.4) 16 (42.1)
Shape 0.023
 Round or ovoid 58 (87.9) 21 (75.0) 37 (97.4)
 Thymic shape 8 (12.1) 7 (25.0) 1 (2.6)
Attenuation 0.892
 Homogeneous 36 (54.5) 15 (53.6) 21 (55.3)
 Heterogeneous 30 (45.5) 13 (46.4) 17 (44.7)
Intralesional fat 0.002c
 Yes 7 (10.6) 7 (25.0) 0 (0.0)
 No 59 (89.4) 21 (75.0) 38 (100.0)
Calcification 0.417
 Yes 5 (7.6) 3 (10.7) 2 (5.3)
 No 61 (92.4) 25 (89.3) 36 (94.7)
Mediastinal fat infiltration 0.051
 Yes 10 (15.2) 1 (3.6) 9 (23.7)
 No 56 (84.8) 27 (96.4) 29 (76.3)
Data are no. (%), unless otherwise noted.
aFrom univariate logistic regression analysis evaluating the association between each patient and lesion feature and lesion status as benign versus malignant, unless otherwise noted.
bMedian (range).
cFisher’s exact test.
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In conclusion, there are features that can be helpful in 
determining a benign etiology for a thymic mass. Intralesional 
fat, midline location, and triangular thymic shape are more 
frequently found in benign thymic lesions. Infiltration of the 
mediastinal fat, particularly in the setting of older age or a 
large mass, may increase the likelihood of a malignant lesion.
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FIGURE 7.  Thymoma in a 63-year-old woman. Contrast-
enhanced computed tomography shows a round, right-sided 
enhancing anterior mediastinal mass.
FIGURE 8.  Thymic carcinoma in a 45-year-old man. 
Contrast-enhanced computed tomography shows an ovoid 
heterogeneous left-sided anterior mediastinal mass.
TABLE 5.  Multivariate Logistic Regression Model for 
Association with Benign Thymic Lesions
Variable OR (95% CI) p
Age (yrs) 0.93 (0.89–0.98) 0.003
Short-axis dimension 0.95 (0.91–1.00) 0.040
Infiltration of mediastinal fat 0.08 (0.01–0.85) 0.036
CI, confidence interval; OR, odds ratio.
